Worldwide Arthralgia (Joint Pain) Clinical Trials Insights, 2020 by Trial Status, Trial Phase, Sponsor Type, End Point Status, Region and Country

DUBLIN, March 18, 2020 /PRNewswire/ -- The "Arthralgia (Joint Pain) Clinical Trials Review H1, 2020" clinical trials has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

This clinical trial report, Arthralgia (Joint Pain) Clinical Trials Review H1, 2020 provides an overview of Arthralgia (Joint Pain) Clinical trials scenario.

The report provides top line data relating to the clinical trials on Arthralgia (Joint Pain). The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Report Scope

    --  The report provides a snapshot of the global clinical trials landscape
    --  Report provides top level data related to the clinical trials by Region,
        Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point
        Status
    --  The report reviews top companies involved and enlists all trials (Trial
        title, Phase, and Status) pertaining to the company
    --  The report provides all the unaccomplished trials (Terminated, Suspended
        and Withdrawn) with reason for unaccomplishment
    --  The Report provides enrollment trends for the past five years
    --  Report provides latest news for the past three months

Reasons to Buy

    --  Assists in formulating key business strategies with regards to
        investment
    --  Helps in identifying prominent locations for conducting clinical trials
        which saves time and cost
    --  Provides top level analysis of Global Clinical Trials Market which helps
        in identifying key business opportunities
    --  Supports understanding of trials count and enrollment trends by country
        in global therapeutics market
    --  Aids in interpreting the success rates of clinical trials by providing a
        comparative scenario of completed and uncompleted (terminated, suspended
        or withdrawn) trials
    --  Facilitates clinical trial assessment of the indication on a global,
        regional and country level

Key Topics Covered

    --  Report Guidance
    --  Clinical Trials Report Coverage
    --  Clinical Trials by Region
    --  Clinical Trials and Average Enrollment by Country
    --  Top Five Countries Contributing to Clinical Trials in Asia-Pacific
    --  Top Five Countries Contributing to Clinical Trials in Europe
    --  Top Countries Contributing to Clinical Trials in North America
    --  Top Countries Contributing to Clinical Trials in Middle East and Africa
    --  Top Countries Contributing to Clinical Trials in Central and South
        America
    --  Clinical Trials by G7 Countries: Proportion of Arthralgia (Joint Pain)
        to Central Nervous System Clinical Trials
    --  Clinical Trials by Phase in G7 Countries
    --  Clinical Trials in G7 Countries by Trial Status
    --  Clinical Trials by E7 Countries: Proportion of Arthralgia (Joint Pain)
        to Central Nervous System Clinical Trials
    --  Clinical Trials by Phase in E7 Countries
    --  Clinical Trials in E7 Countries by Trial Status
    --  Clinical Trials by Phase
    --  In Progress Trials by Phase
    --  Clinical Trials by Trial Status
    --  Clinical Trials by End Point Status
    --  Subjects Recruited Over a Period of Time
    --  Clinical Trials by Sponsor Type
    --  Prominent Sponsors
    --  Top Companies Participating in Arthralgia (Joint Pain) Therapeutics
        Clinical Trials
    --  Prominent Drugs
    --  Clinical Trial Profile Snapshots

Companies Mentioned

    --  Anika Therapeutics Inc.
    --  ESM Technologies LLC
    --  GlaxoSmithKline PLC
    --  Grunenthal GmbH
    --  IBSA Institut Biochimique S.A.
    --  Johnson & Johnson
    --  Nanjing Easeheal Pharmaceutical Co. Ltd.
    --  Novartis AG
    --  QPS Holdings LLC
    --  Reckitt Benckiser Group PLC

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/6h0vfp

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/worldwide-arthralgia-joint-pain-clinical-trials-insights-2020-by-trial-status-trial-phase-sponsor-type-end-point-status-region-and-country-301026237.html

SOURCE Research and Markets